ERX:ARCA-Direxion Energy Bull 3X Shares (USD)

ETF | Trading--Leveraged Equity | NYSE Arca

Last Closing

USD 70.8

Change

+1.44 (+2.08)%

Market Cap

USD 0.44B

Volume

0.50M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The investment seeks daily investment results, before fees and expenses, of 300% of the performance of the Energy Select Sector Index. The fund creates long positions by investing at least 80% of its assets in the securities that comprise the Energy Select Sector Index and/or financial instruments that provide leveraged and unleveraged exposure to the index. The index is provided by S&P Dow Jones Indices (the "index provider") and includes domestic companies from the energy sector which includes the following industries: oil, gas and consumable fuels; and energy equipment and services. The fund is non-diversified.

Inception Date: 06/11/2008

Primary Benchmark: S&P Energy Select Sector TR USD

Primary Index: S&P 500 TR USD

Gross Expense Ratio: 0.96%

Management Expense Ratio: 1.08 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Holdings

N/A

Symbol Company Name Allocation
SCPS Scopus Biopharma Inc 5.84 %
Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-03-28 )

Largest Industry Peers for Trading--Leveraged Equity

Symbol Name Mer Price(Change) Market Cap
SOXL Direxion Daily Semiconductor B.. 1.10 %

+2.39 (+6.39%)

USD 10.94B
QLD ProShares Ultra QQQ 0.95 %

+2.47 (+3.11%)

USD 5.97B
SSO ProShares Ultra S&P500 0.90 %

+1.39 (+1.95%)

USD 4.66B
FNGU MicroSectors FANG+ Index 3X Le.. 0.00 %

+24.05 (+8.54%)

USD 4.21B
SPXL Direxion Daily S&P500® Bull 3.. 1.00 %

+3.30 (+2.80%)

USD 4.15B
TECL Direxion Daily Technology Bull.. 1.17 %

+2.18 (+3.24%)

USD 3.23B
UPRO ProShares UltraPro S&P500 0.92 %

+1.79 (+2.89%)

USD 2.73B
FAS Direxion Daily Financial Bull .. 1.04 %

-0.80 (-0.79%)

USD 2.45B
TNA Direxion Daily Small Cap Bull .. 1.10 %

+0.95 (+2.76%)

USD 2.23B
LABU Direxion Daily S&P Biotech Bul.. 1.14 %

+3.79 (+4.53%)

USD 1.24B

ETFs Containing ERX

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Leveraged Equity) Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 25.15% 81% B- 94% A
Dividend Return 0.90% 95% A 50% F
Total Return 26.06% 81% B- 94% A
Trailing 12 Months  
Capital Gain 23.26% 32% F 73% C
Dividend Return 3.15% 95% A 47% F
Total Return 26.40% 35% F 73% C
Trailing 5 Years  
Capital Gain 211.89% 88% B+ 94% A
Dividend Return 19.82% 92% A 71% C-
Total Return 231.72% 86% B+ 94% A
Average Annual (5 Year Horizon)  
Capital Gain 76.83% 87% B+ 97% N/A
Dividend Return 80.01% 88% B+ 97% N/A
Total Return 3.18% 92% A 64% D
Risk Return Profile  
Volatility (Standard Deviation) 262.16% 13% F 3% F
Risk Adjusted Return 30.52% 75% C 56% F
Market Capitalization 0.44B 70% C- 40% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.